08.27.25 -- Insights From A Digital Health Intervention Trial For Heart Failure

The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.

Oncology clinical trials face unique challenges in patient recruitment and retention due to barriers such as awareness, logistical constraints, and eligibility criteria.

Determining a drug candidate’s probability of commercial success is a significant phase in the drug development process. There is no room for error.

Julio Martinez-Clark, CEO of bioaccess, highlights the benefits of running clinical trials in Latin America.

Explore the growing role of real-world data (RWD) and tokenization in enhancing clinical research and patient-centered evidence generation.

Following these tips will ensure high-quality plain language summaries (PLS) that meet EU parameters while clearly communicating clinical trial information to patients and the public.

Launching a study is complex, and the time between protocol approval and the first patient visit has increased dramatically. How can companies reverse this trend and accelerate study start-ups?

Watch and see how this suite of solutions connects insights, technology, and expertise to maximize an asset's probability of success in a complex and competitive environment.